metricas
covid
Buscar en
Actas Urológicas Españolas
Toda la web
Inicio Actas Urológicas Españolas Segunda resección en pacientes con tumores vesicales ta-t1
Journal Information
Vol. 25. Issue 8.
Pages 553-558 (January 2001)
Share
Share
Download PDF
More article options
Vol. 25. Issue 8.
Pages 553-558 (January 2001)
Segunda resección en pacientes con tumores vesicales ta-t1
Visits
1551
F.I. Rodríguez-rubio cortadellas1, S. Garrido insua, J. Bachiller burgos, V. Beltrán aguilar, C. Varo solís, C. Sánchez bernal, A. Juárez soto, D. González moreno
Servicio de Urología
D. Rivas aguayo**, A. Hens pérez*
* Servicio de Anatomía Patológica
** Servicio de Medicina Preventiva y Salud Pública. Hospital Universitario de Puerto Real. Cádiz
This item has received
Article information
Resumen
Objetivo

Estudiar la incidencia de tumor “residual/recidivante” tras segunda resección precoz (2ª RTU), y que factores influyen en su hallazgo

Material y método

Estudio prospectivo de 40 pacientes con neoplasia vesical superficial a los que se les realizó una 2ª RTU precoz. Como posibles factores de riesgo de hallazgo de tumor se estudiaron el intervalo de tiempo entre ambas RTU, el estadio, el grado, el número de implantes tumorales, el tamaño de los implantes, localización dentro de la vejiga, tumor primario o recidivante y el patrón tumoral

Resultados

Al realizar la 2ª RTU se confirmó histológicamente tumor en 14 (37,8%) de 37 pacientes con tumores Ta-T1 (excluimos aquellos con afectación focal de la muscular): 10 (71,5%) eran tumores macroscópicamente visibles, en 4 casos (28,5%) se encontró tumor al biopsiar las áreas de cicatriz/edema de la resección anterior. No encontramos asociación entre la presencia de tumor en la 2ª RTU y ninguna de las variables en estudio

Conclusiones

La erradicación de tumor vesical superficial mediante RTU no se consigue en un elevado porcentaje de pacientes. La cistoscopia a los tres meses no puede excluir tumor residual. Aunque hemos encontrado 37,8% de tumor en la 2ª RTU, actualmente no podemos recomendarla de forma rutinaria en los tumores vesicales superficiales

Palabras clave:
Tumor superficial de vejiga
Seguimiento
Recidiva
Abstract
Objetives

To study the incidence of “residual/recurrence” tumor after a second bladder resection (2nd TUR)

Methods

40 patients with new or recurrent superficial bladder tumor underwent repeat transurethral resection within 3 months after the initial resection. 37 patients were staged as Ta-T1. We study the incidence of tumor after the 2nd TUR both macroscopicaly detected or included in the bladder scar. We also study the influence of possible factors as the time between both resections, stage, grade, number of tumor size, localization in the bladder, primary or recurrent tumor and tumor pattern

Results

After the 2nd TUR we found tumor in 14 of 37 (37,8%) Ta-T1 bladder tumors. Among the 14 tumors, 10 (71,5%) were macroscopicaly visible tumors and 4 cases the tumor were found after resection of the bladder scar of the first resection. We did not find relation between the presence of tumor in the 2nd TUR and any of the variables

Conclusions

After a TUR of superficial bladder tumor the complete removal of tumor is not always achieved. The early 3 months cystoscopy may not find residual tumor. Although we have found tumor in 37,8% in the 2ªTUR we can not recommend routine 2nd TUR in superficial bladder cancer

Key words:
Bladder neoplasm
Recurrence
Follow-up

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos